Inducible clindamycin resistance among clinically significant staphylococcus aureus isolates in a tertiary care centre

  • NISHA SADANANDAN SNIMS ,ERNAKULAM
Keywords: iMLSB, cMLSB, MS Phenotype, D test, MRSA, MSSA, MIC

Abstract

INDUCIBLE CLINDAMYCIN RESISTANCE AMONG CLINICALLY SIGNIFICANT STAPHYLOCOCCUS AUREUS ISOLATES IN A TERTIARY CARE CENTRE

                                        ABSTRACT

Objective

 Staphylococcus aureus isolates with inducible clindamycin resistance may lead to  therapeutic failure on treating with Clindamycin. Aim:

To detect inducible clindamycin resistance of clinically significant Staphylococcus aureus  isolates and MIC of clindamycin in them.

Study design

Crossectional study

Study subjects

The study was conducted in 200 clinically significant Staphylococcus aureus isolates from Govt medical college, Thrissur Kerala, India  over a period of one year

Study methods

D test was done and  iMLSB, cMLSB, MS phenotypes were identified. Epsilometer test was done for determining the MIC of Clindamycin.. Statistical analysis was done using IBM statistical package for social sciences version 25(SPSS).

Results

Of the total  200 samples 132(66%) were MSSA and 68(34%) were MRSA.MS phenotypes 60(30%), iMLSB phenotype 53(26.5%),cMLSB phenotype 44 (22%), Erythromycin and Clindamycin sensitive strains 41(20.5%) and resistant strains 2 (1%). Inducible and constitutive resistance to clindamycin were more in MRSA.92% of iMLSB phenotypes  and 96% of MS phenotypes had MIC < 0.5(sensitive). 8% iMLSB phenotypes and 96% of cMLSB phenotypes had MIC >4(resistant). One isolate with  cMLSB phenotype  had MIC in intermediate range .

Conclusion

Prevalence of inducible clindamycin resistance in our hospital is high and more common among MRSA. E test helped to determine MIC in intermediate range (shown by  cMLSB phenotype )which is not possible by doing disc diffusion method alone.  Most common phenotype isolated was MS phenotype.

Keywords

iMLSB, cMLSB, MS Phenotype, D test, MRSA, MSSA, MIC

 

 

 

 

 

 

Downloads

Download data is not yet available.

References

1.Baral R, Khanal B. Inducible clindamycin resistance in Staphylococcus aureus strains isolated from clinical samples. International Journal of Biomedical Research. 2017 Feb 28;8(2):81-4.
2. Regmi RS, Khadka S, Sapkota S, Magar ST, Adhikari S, Subedi S, Shrestha P, Rana JC. Phenotypic detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in Bharatpur hospital. Journal of College of Medical Sciences-Nepal. 2020 Sep 30;16(3):178-83.
3.Kavitha AV. Inducible clindamycin resistance among Staphylococcus aureus isolates from various clinical samples. University Journal of Pre and Paraclinical Sciences. 2020 Dec 30;6(8).
2. 4.Thapa D, Pyakurel S, Thapa S, Lamsal S, Chaudhari M, Adhikari N, Shrestha D. Staphylococcus aureus with inducible clindamycin resistance and methicillin resistance in a tertiary hospital in Nepal. Tropical Medicine and Health. 2021 Dec;49(1):1-7.

5. Hodille E, Badiou C, Bouveyron C, Bes M, Tristan A, Vandenesch F, Lina G, Dumitrescu O. Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains. Annals of clinical microbiology and antimicrobials. 2018 Dec;17(1):38

6. Mahfouz AA, Said HS, Elfeky SM, Shaaban MI. Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates. Antibiotics. 2023 Mar 2;12(3):503.

7. Garg S, Mahajan RK, Chhakchhuak Z, Tluanpuii V. Clindamycin: An adjunct option in drug-resistant staphylococcal infections. CHRISMED Journal of Health and Research. 2022 Oct 1;9(4):242-5.

8.Moosavian M, Shoja S, Rostami S, Torabipour M, Farshadzadeh Z. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus due to erm genes, Iran. Iran J Microbiol. 2014 Dec;6(6):421-7. PMID: 25926961; PMCID: PMC4411429.

1.9. Fasih N, Irfan S, Zafar A, Khan E, Hasan R. Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: report from a tertiary care hospital Karachi, Pakistan. Journal of the Pakistan Medical Association. 2010;60(9):750.

10.Lyall KS,Guptha V,Chhina D.Inducible clindamycin resistance among clinical isolates of Staphhylococcus aureus.J Mahatma Gandhi Inst Med Sci 2013;18:112-5

211.Ghanbari F, Ghajavand H, Havaei R, Jami MS, Khademi F, Heydari L, Shahin M, Havaei SA. Distribution of erm genes among Staphylococcus aureus isolates with inducible resistance to clindamycin in Isfahan, Iran. Advanced biomedical research. 2016;5.

12. Gangurde N, Bajaj P, Phatale S. Prevalence of inducible clindamycin resistance among staphylococcus aureus isolates in a tertiary care hospital: an alarm before “no antibiotic era”. Journal of Evolution of Medical and Dental Sciences. 2014 May 5;3(18):4839-47.

13. Sharma A, Sharma RP, Bhise M, Shaikh NK. Inducible Clindamycin resistance among clinical isolates of Staphylococcus aureus from a tertiary care teaching hospital in Solapur, Maharashtra. Indian Journal of Applied Research. 2019 Aug 12;9(7).

14. Jayachandiran AL, Kandasamy B, Vilwanatha S, Muralidharan V. A Study of Inducible Clindamycin Resistance among Staphylococcus aureus Skin and Soft Tissue Infections in A Tertiary Care Hospital. Journal of Microbiology and Infectious Diseases. 2019 Sep 1;9(03):125-8.

15. Sah P, Khanal R, Lamichhane P, Upadhaya S, Lamsal A, Pahwa VK. Inducible and constitutive clindamycin resistance in Staphylococcus aureus: An experience from Western Nepal. Int J Biomed Res. 2015;6:316-9

16. Mama M, Aklilu A, Misgna K, Tadesse M, Alemayehu E. Methicillin-and Inducible Clindamycin-Resistant Staphylococcus aureus among Patients with Wound Infection Attending Arba Minch Hospital, South Ethiopia. International journal of microbiology. 2019;2019..

17. Kale S, Patil A. The study of inducible and constitutive clindamycin resistance in Staphylococcus aureus isolates from clinical samples in a teriary care hospital in central india. International Journal of Scientific Research. 2019 Jul 17;8(4).

18. Regha IR, Harichandran D, Sulekha B. Inducible Clindamycin Resistance among Clinical Isolates of Staphylococcus aureus in a Tertiary Care Centre, Kerala, India. Int. J. Curr. Microbiol. App. Sci. 2016;5(4):929-34.

19. Khan F, Ali S, Sultan A, Rizvi M, Khatoon A, Shukla I, Khan HM. A study of inducible clindamycin resistance in erythromycin resistant clinical isolates of Staphylococcus species. Asian Journal of Medical Sciences. 2015 May 24;6(6):48-52.

20. Ghogare HS, Hatkar SS, Bansal MP. Phenotypic detection of inducible clindamycin resistance among the clinical isolates of Staphylococcus aureus by using D-test. IJHSR. 2014;4(3):149-53.

21. Manjunath V, Eshwar S, Ramya TG, Mridula RP, Sharma AD. test–its role in detection of inducible resistance to clindamycin in Staphylococcus aureus with special reference to MRSA. Inl J Biol Med Res. 2012;3(1):1430-2.

22. Reddy PS, Suresh R. Phenotypic detection of inducible clindamycin resistance among the clinical isolates of Staphylococcus aureus by using the lower limit of inter disk space. J Microbiol Biotech Res. 2012;2(2):258-64.


23. Sireesha P, Setty CR. Detection of various types of resistance patterns and their correlation with minimal inhibitory concentrations against clindamycin among methicillin-resistant Staphylococcus aureus isolates. Indian journal of medical microbiology. 2012 Apr 1;30(2):165.
How to Cite
SADANANDAN, N. (2024). Inducible clindamycin resistance among clinically significant staphylococcus aureus isolates in a tertiary care centre . Tropical Journal of Pathology and Microbiology, 9(4), 32-39. Retrieved from https://pathology.medresearch.in/index.php/jopm/article/view/631
Section
Original Article